IO Biotech, Inc. Announces Pricing of Initial Public Offering
5 Nov, 2021 | Press Releases
Congratulations to our portfolio company IO Biotech on the successful IPO on NASDAQ. Great achievement for this pioneering company, and a milestone in the development of new pioneering treatments for Cancer patients based on the company’s T-win technology.
All news articles